Levels of MDSCs and CD163+ M2 macrophages are found to be elevated correlatively in NSCLC patients after they receive ionizing radiation therapy, pointing towards potential biomarkers during NSCLC diagnosis and favorable therapeutic response [81]. The gene discussed is CD163; the disease is non-small cell lung carcinoma.